Business & Finance
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
Key Points
Jul 7th, 2026 SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers On this episode of Stock Movers: - Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv. - Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy...
Jul 7th, 2026
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
On this episode of Stock Movers: - Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv. - Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy Crinetics for $10 billion in cash to expand into endocrinology. - SpaceX (SPCX) is lower even though at least six brokers, including Morgan Stanley and Goldman Sachs, have started coverage of SpaceX with buy-equivalent ratings. SpaceX’s addition to the Nasdaq 100 should provide considerable support to the stock, considering the number of funds that track the tech-heavy benchmark.
[Image text:] Bloomberg
Radio
018
SPACEX
159.01
L14A
STOCKS TO WATCH INPREMARKET TRADING
SpaceX (ORG)
Crinetics Pharmaceuticals Soars (ORG)
Stock Movers: - Fiserv (ORG)
FISV (ORG)
the Wall Street Journal (ORG)
JPMorgan Chase (ORG)
Bank of America (ORG)
Wells Fargo (ORG)
PNC Financial Services Group (ORG)
Fiserv (ORG)
CRNC (ORG)
Vertex Pharmaceuticals (ORG)
Crinetics (ORG)
Morgan Stanley (ORG)
Goldman Sachs (ORG)